Detalhe da pesquisa
1.
Infection Prevention and Control in Correctional Settings.
Emerg Infect Dis;
30(13): S88-S93, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38561855
2.
High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons.
J Public Health Manag Pract;
25(2): E1-E6, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30024493
3.
Tuberculosis control in a large urban jail: discordance between policy and reality.
J Public Health Manag Pract;
14(5): 442-7, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18708887
4.
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Arch Intern Med;
166(17): 1863-70, 2006 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17000943
5.
Evaluation of investigations conducted to detect and prevent transmission of tuberculosis.
JAMA;
287(8): 991-5, 2002 Feb 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11866646
6.
Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States.
South Med J;
95(4): 414-20, 2002 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11958239
7.
Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.
JAMA;
288(2): 165-6, 2002 Jul 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12095379